60 results
6-K
EX-10.3
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental … (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of ADSs
6-K
EX-10.2
BLRX
Bioline Rx Ltd
21 Sep 22
Current report (foreign)
8:00am
Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined … be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes
6-K
EX-99
BLRX
Bioline Rx Ltd
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
income and expense in the statement of comprehensive loss.
The fair value of the warrants is computed using the Black-Scholes option pricing model … loss.
The fair value of the warrants is computed using the Black-Scholes option pricing model. The fair value of the warrants upon issuance
6-K
EX-3
BLRX
Bioline Rx Ltd
27 Oct 21
2021 Annual General Meeting of Shareholders
5:05pm
Instruction On Reverse Side.
Please make your marks like this: ☒ Use dark black pencil or pen only
For
Against
Abstain
Mark, sign and date your Voting
6-K
EX-99
BLRX
Bioline Rx Ltd
26 Feb 21
Extraordinary General Meeting of Shareholders on
4:30pm
your marks like this: ⌧ Use dark black pencil or pen only
For
Against
Abstain
To approve an amendment to Section 4.3 of the Company’s Compensation
6-K
EX-99
9vefvv7l0exw t9v
19 Aug 20
2020 Annual General Meeting of Shareholders
4:34pm
6-K
EX-99
hj8r1p2zzgtmt wrax
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
82rw5a
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.2
1ouxbzrm5
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
6-K
EX-99
ozvuhmxf3y28x4
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
pjy 5rh50gilcj0
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
dodz6bum
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
6-K
EX-99
uxxu9bgxlbzl6 aogkm
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
1lx9vu2lh6htqo 04v
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
6-K
EX-99
6084zn
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
qarxc vami
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
kplmfsd 06e4
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
6-K
EX-99
9xgvk lha2wuizbbsto
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
lzlx7yqc afxh0ytx
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am